benzocaine 0.2 MG/MG / zinc chloride 0.001 MG/MG Oral Gel

RxCUI
1249105
RxNorm name
benzocaine 0.2 MG/MG / zinc chloride 0.001 MG/MG Oral Gel
Display name
Benzocaine/Zinc chloride (Oral Gel)
Full name
benzocaine 0.2 MG/MG / zinc chloride 0.001 MG/MG Oral Gel
Term type
SCD
Status
Active
Strength
20-0.1%
Dose form
Gel
Route
Oral Gel
Updated
2026-06-06 07:16:27

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
052012
Active start
052012
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
benzocaine0.2 MG / 1 MGbenzocainebenzocaine
zinc chloride0.001 MG / 1 MGzinc chloridezinc chloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Gel346169

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzocaine1399
zinc chloride39937

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRbenzocaine 0.2 MG/MG / zinc chloride 0.001 MG/MG Oral GelNAMES
RxNorm Namebenzocaine 0.2 MG/MG / zinc chloride 0.001 MG/MG Oral GelNAMES
RxNorm Synonymbenzocaine 20 % / zinc chloride 0.1 % Oral GelNAMES
TTYSCDATTRIBUTES
SPL_SET_ID093f3545-1d8e-48a3-a533-e9c3ae6d740bCODES
RxCUI1249105CODES
MMSL_CODEBD38515CODES
MMSL_CODECD38515CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
10157-2106-110157-2106KANKA Benzocaine and ZINC CHLORIDEBlistex IncM022
10157-2106-210157-2106KANKA Benzocaine and ZINC CHLORIDEBlistex IncM022

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M02210157-2106KANKA Benzocaine and ZINC CHLORIDEOTC MONOGRAPH DRUGBlistex Inc

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
10157210601rxnav_ndcsyes
10157210602rxnav_ndcsyes
41388020392rxnav_ndcsyes
10157949301rxnav_historical_indirect
10157949302rxnav_historical_indirect

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
093f3545-1d8e-48a3-a533-e9c3ae6d740bbenzocaine 0.2 MG/MG / zinc chloride 0.001 MG/MG Oral GelSCD2KANKA ® SoftBrush20241212
093f3545-1d8e-48a3-a533-e9c3ae6d740bbenzocaine 20 % / zinc chloride 0.1 % Oral GelPSN2KANKA ® SoftBrush20241212
093f3545-1d8e-48a3-a533-e9c3ae6d740bbenzocaine 20 % / zinc chloride 0.1 % Oral GelSY2KANKA ® SoftBrush20241212

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
093f3545-1d8e-48a3-a533-e9c3ae6d740bKANKA ® SoftBrushBlistex Inc20241212

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4benzocaine
ATCR02ADAnesthetics, localATC1-4benzocaine
ATCB05XAElectrolyte solutionsATC1-4zinc chloride
ATCN01BAEsters of aminobenzoic acidATC1-4benzocaine
ATCC05ADLocal anestheticsATC1-4benzocaine
FDASPLN0000185508Standardized Chemical AllergenEPChas_epcbenzocaine
FDASPLN0000184306Cell-mediated ImmunityPEhas_pebenzocaine
FDASPLN0000175629Increased Histamine ReleasePEhas_pebenzocaine
MEDRTD001566BenzocaineCHEMhas_ingredientbenzocaine
MEDRTD002712ChloridesCHEMhas_ingredientzinc chloride
MEDRTD017967Zinc CompoundsCHEMhas_ingredientzinc chloride
MEDRTD001424Bacterial InfectionsDISEASEci_withbenzocaine
MEDRTD002056BurnsDISEASEmay_treatbenzocaine
MEDRTD003139Common ColdDISEASEmay_treatzinc chloride
MEDRTD004342Drug HypersensitivityDISEASEci_withzinc chloride
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzocaine
MEDRTD004433EaracheDISEASEmay_treatbenzocaine
MEDRTD005401Fissure in AnoDISEASEmay_treatbenzocaine
MEDRTD006484HemorrhoidsDISEASEmay_treatbenzocaine
MEDRTD006561Herpes SimplexDISEASEmay_treatbenzocaine
MEDRTD019226Oral UlcerDISEASEmay_treatbenzocaine
MEDRTD010032Otitis ExternaDISEASEmay_treatbenzocaine
MEDRTD010033Otitis MediaDISEASEmay_treatbenzocaine
MEDRTD010146PainDISEASEmay_preventbenzocaine
MEDRTD011537PruritusDISEASEmay_treatbenzocaine
MEDRTD012883Skin UlcerDISEASEmay_treatzinc chloride
MEDRTD014098ToothacheDISEASEmay_treatbenzocaine
MEDRTD014947Wounds and InjuriesDISEASEmay_treatzinc chloride
MEDRTN0000000226Acid-Base ActivityMOAhas_moazinc chloride
MEDRTN0000000220Electrolyte ActivityMOAhas_moazinc chloride
MEDRTN0000000163Enzyme InteractionsMOAhas_moazinc chloride
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moabenzocaine
MEDRTN0000008301Astringent ActivityPEhas_pezinc chloride
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pebenzocaine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.2 MG/MG / 0.001 MG/MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSCD
CODESMMSL_CODEBD38515
CODESMMSL_CODECD38515
CODESRxCUI1249105
CODESSPL_SET_ID093f3545-1d8e-48a3-a533-e9c3ae6d740b
NAMESPrescribable Synonymbenzocaine 20 % / zinc chloride 0.1 % Oral Gel
NAMESRXNAV_STRbenzocaine 0.2 MG/MG / zinc chloride 0.001 MG/MG Oral Gel
NAMESRxNorm Namebenzocaine 0.2 MG/MG / zinc chloride 0.001 MG/MG Oral Gel
NAMESRxNorm Synonymbenzocaine 20 % / zinc chloride 0.1 % Oral Gel
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon